Insulin Aspart

Product NDC: 70518-2823
11-digit product format: 705182823
Labeler code: 70518
Product ID: 70518-2823_e557ba60-cc95-a218-e053-2995a90af997
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: insulin aspart
Dosage form: INJECTION, SOLUTION
Route: INTRAVENOUS; SUBCUTANEOUS
Labeler: REMEDYREPACK INC.
Application: BLA020986
Marketing category: BLA
Marketing start: 2020-08-03
Marketing end: 0000-00-00
Substance: INSULIN ASPART
Active strength: 100 [iU]/mL
Pharmacologic classes: Insulin Analog [EPC], Insulin [CS]
NDC exclude flag: No
Listing certified through: 2023-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded product	product	70518-2823		D	Discontinued by firm		2026-08-11
excluded package	package	70518-2823	70518-2823-0	D	Discontinued by firm		2026-08-11

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 2 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Archive	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product	70518-2823		D	Discontinued by firm		excluded / ndc_excluded.zip	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	70518-2823	70518-2823-0	D	Discontinued by firm		excluded / ndc_excluded.zip	`d630ba8d3edf…`	`732f749b63fb…`

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
70518-2823	INSULIN ASPART INJECTION, SOLUTION [REMEDYREPACK INC.]	5	Legacy NDC	20240308_8dddb455-b5f3-4317-a7ec-de90a0311ae3.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 7 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Insulin Aspart	INSULIN ASPART	REMEDYREPACK INC.	b3d77cb0-cd47-441f-8f54-5329c655da9c	2026-01-14	Warnings, Adverse reactions	Exact identifier application number: BLA020986
Insulin Aspart	INSULIN ASPART	A-S Medication Solutions	c3e4c46e-5211-4f05-b7ab-1e9ad270876b	2024-09-11	Warnings, Adverse reactions	Exact identifier application number: BLA020986
Insulin Aspart	INSULIN ASPART	A-S Medication Solutions	bfd2b192-35e5-4773-ab73-802565b2ad78	2024-03-14	Warnings, Adverse reactions	Exact identifier application number: BLA020986
NOVOLOG	INSULIN ASPART	A-S Medication Solutions	13891e5a-e57a-46e8-911c-2f680352b52b	2023-12-15	Warnings, Adverse reactions	Exact identifier application number: BLA020986
NOVOLOG	INSULIN ASPART	A-S Medication Solutions	e172b4f8-9b25-4019-8e09-afc10b2f30c9	2023-12-09	Warnings, Adverse reactions	Exact identifier application number: BLA020986
Insulin Aspart	INSULIN ASPART	Novo Nordisk Pharma, Inc.	bee5b358-c863-420b-be73-ced2e920c499	2023-02-28	Warnings, Adverse reactions	Exact identifier application number: BLA020986
Insulin Diluting Medium for NovoLog	WATER INJECTION	Novo Nordisk	3a1e73a2-3009-40d0-876c-b4cb2be56fc5	2023-02-28	Warnings, Adverse reactions	Exact identifier application number: BLA020986

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLA	Proprietary name	Proper name	License type	Status	Latest source
020986	Novolog	insulin aspart	351(a)	Rx	2026-07-01

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
D933668QVX	INSULIN ASPART	116094-23-6	INSULIN ASPART

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Marketing start	Marketing end	Sample	Exclude flag	Status
70518-2823-0	70518282300	1 VIAL, GLASS in 1 CARTON (70518-2823-0) > 10 mL in 1 VIAL, GLASS	2020-08-03	0000-00-00	No	No	Current